http://orcid.org/0000-0002-0179-512X
Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Konstantinos Katsoulis, Maria Kipourou & Stelios Loukides. (2022) Reduction/elimination of blood eosinophils in severe asthma: should there be a safety consideration?. Expert Opinion on Biological Therapy 22:3, pages 377-384.
Read now
Read now
Jonathan Corren, Martin Karpefors, Åsa Hellqvist, Jane R Parnes & Gene Colice. (2021) Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b Study. Journal of Asthma and Allergy 14, pages 1-11.
Read now
Read now
Gail M. Gauvreau, Roma Sehmi, Christopher S. Ambrose & Janet M. Griffiths. (2020) Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma. Expert Opinion on Therapeutic Targets 24:8, pages 777-792.
Read now
Read now
Dan Yang, Tingxuan Huang, Bicui Liu, Zhuman Du & Chuntao Liu. (2020) Dupilumab in patients with uncontrolled asthma: type 2 biomarkers might be predictors of therapeutic efficacy. Journal of Asthma 57:1, pages 79-81.
Read now
Read now
Alice Grey & Constance H Katelaris. (2019) Dupilumab in the Treatment of Asthma. Immunotherapy 11:10, pages 859-872.
Read now
Read now
Articles from other publishers (39)
Andrew Menzies-Gow, Christopher S. Ambrose, Gene Colice, Gillian Hunter, Bill Cook, Nestor A. Molfino, Jean-Pierre Llanos & Elliot Israel. (2023) Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study. Advances in Therapy 40:11, pages 4957-4971.
Crossref
Crossref
Irena Krčmová & Jakub Novosad. (2023) Alarmins - novel targets for biological therapy. Vnitřní lékařství 69:6, pages 352-358.
Crossref
Crossref
Olaia Sardon-Prado, Carolina Diaz-Garcia, Paula Corcuera-Elosegui, Javier Korta-Murua, Jose Valverde-Molina & Manuel Sanchez-Solis. (2023) Severe Asthma and Biological Therapies: Now and the Future. Journal of Clinical Medicine 12:18, pages 5846.
Crossref
Crossref
Jonathan CorrenAndrew Menzies-Gow, Geoffrey ChuppElliot IsraelStephanie KornBill CookChristopher S. Ambrose, Åsa HellqvistStephanie L. Roseti, Nestor A. MolfinoJean-Pierre Llanos, Neil Martin, Karin BowenJanet M. GriffithsJane R. ParnesGene Colice. (2023) Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials. American Journal of Respiratory and Critical Care Medicine 208:1, pages 13-24.
Crossref
Crossref
Muruvvet Yanaz, Bulent Karadag & Kostas Priftis. 2023. Airway diseases. Airway diseases
1
14
.
Eustachio Nettis, Luisa Brussino, Vincenzo Patella, Laura Bonzano, Aikaterini Detoraki, Elisabetta Di Leo, Maria Maddalena Sirufo, Cristiano Caruso, Fabio Lodi Rizzini, Mariaelisabetta Conte, Mona-Rita Yacoub, Massimo Triggiani, Erminia Ridolo, Luigi Macchia, Giovanni Rolla, Raffaele Brancaccio, Amato De Paulis, Giuseppe Spadaro, Danilo Di Bona, Angela Maria D’Uggento, Lia Ginaldi, Francesco Gaeta, Eleonora Nucera, Kliljeda Jaubashi, Danilo Villalta, Lorenzo Dagna, Domenico Ciotta, Francesco Pucciarini, Diego Bagnasco, Giorgio Celi, Fulvia Chieco Bianchi, Lorenzo Cosmi, Maria Teresa Costantino, Maria Angiola Crivellaro, Simona D’Alò, Pietro del Biondo, Stefano Del Giacco, Mario Di Gioacchino, Linda Di Pietro, Elisabetta Favero, Sebastiano Gangemi, Gabriella Guarnieri, Enrico Heffler, Maria Stefania Leto Barone, Carla Lombardo, Francesca Losa, Andrea Matucci, Paola Lucia Minciullo, Paola Parronchi, Giovanni Passalacqua, Stefano Pucci, Oliviero Rossi, Lorenzo Salvati, Michele Schiappoli, Gianenrico Senna, Andrea Vianello, Alessandra Vultaggio, Yang Baoran, Cristoforo Incorvaia & Giorgio Walter Canonica. (2022) Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life. Clinical and Molecular Allergy 20:1.
Crossref
Crossref
Austin R. Swisher, Rijul S. Kshirsagar, Nithin D. AdappaJonathan Liang. (2021)
Dupilumab Adverse Events in Nasal Polyp Treatment: Analysis of
FDA
Adverse Event Reporting System
. The Laryngoscope 132:12, pages 2307-2313.
Crossref
Crossref
Evelyn Evelyn, Putra Brillian Djohan & Fauna Herawati. (2022) Dupilumab Efficacy and Safety as an Add-On Therapy in Uncontrolled Asthma Patients: A Systematic Review. Journal of Health Sciences 15:03, pages 218-230.
Crossref
Crossref
A. Yu. Kraposhina, E. A. Sobko, I. V. Demko, A. B. Katser, O. V. Kazmerchuk, Yu. I. Abramov & S. V. Chubarova. (2022) New options for severe asthma. Meditsinskiy sovet = Medical Council 16:18, pages 20-28.
Crossref
Crossref
Mohamed Sayed Zaazouee, Asmaa Gomaa Alwarraqi, Yasmine Adel Mohammed, Mohamed A. Badheeb, Abdullah Mohamed Farhat, Mohammed Eleyan, Afnan Morad, Marwa Abdel-Aziz Zeid, Aya Shaban Mohamed, Hazem AbuEl-Enien, Ahmed Abdelalim, Ahmed Bostamy Elsnhory, Yasmin S. M. Hrizat, Nagat Taha Altahir, Doaa Atef, Alaa Ahmed Elshanbary, Khalaf F. Alsharif, Khalid J. Alzahrani, Mohammad Algahtani, Abdulrahman Theyab, Yousef M. Hawsawi, Ahmed A. Aldarmahi & Mohamed M. Abdel-Daim. (2022) Dupilumab efficacy and safety in patients with moderate to severe asthma: A systematic review and meta-analysis. Frontiers in Pharmacology 13.
Crossref
Crossref
Mahesh Mamilla, Nikhita Yadav Maddeti, Pawan Kumar Thada, Iman Mahamoud, Sarosh Sarwar, Madeeha Subhan Waleed, Shikha Yadav, Manaal Mustansir, Anuradha Raut, George Yatzkan & Javier Perez-Fernandez. (2022) Use of Dupilumab in Glucocorticoid-Dependent Asthma. Southern Medical Journal 115:8, pages 611-615.
Crossref
Crossref
A. G. Chuchalin, S. N. Avdeev, Z. R. Aisanov, A. S. Belevskiy, O. S. Vasil’eva, N. A. Geppe, G. L. Ignatova, N. P. Knyazheskaya, A. B. Malakhov, N. I. Meshcheryakova, N. M. Nenasheva, R. S. Fassakhov, R. M. Khaitov, N. I. Il’ina, O. M. Kurbacheva, N. G. Astafieva, I. V. Demko, D. S. Fomina, L. S. Namazova-Baranova, A. A. Baranov, E. A. Vishneva & G. A. Novik. (2022) Federal guidelines on diagnosis and treatment of bronchial asthma. PULMONOLOGIYA 32:3, pages 393-447.
Crossref
Crossref
Evanthia P. Perikleous, Paschalis Steiropoulos, Evangelia Nena & Emmanouil Paraskakis. (2022) Biologic Therapies in Pediatric Asthma. Journal of Personalized Medicine 12:6, pages 999.
Crossref
Crossref
Rory Chan, Kirsten Stewart, Rasads Misirovs & Brian J. Lipworth. (2022) Targeting Downstream Type 2 Cytokines or Upstream Epithelial Alarmins for Severe Asthma. The Journal of Allergy and Clinical Immunology: In Practice 10:6, pages 1497-1505.
Crossref
Crossref
S. Shahzad Mustafa, Sara Patrawala & Sandhya Khurana. (2022) Use of biologics for the treatment of moderate-to-severe asthma: the age of personalized medicine. Current Opinion in Pulmonary Medicine 28:3, pages 266-273.
Crossref
Crossref
Aşkın Gülşen. 2022. Recent Advances in Asthma Research and Treatments. Recent Advances in Asthma Research and Treatments.
Alexis Arasu, Niyati Sharma, Anousha Yazdabadi & Michael Sladden. (2021) Dual biologic therapy with Omalizumab and Dupilumab for refractory atopic disease. Australasian Journal of Dermatology 63:1, pages 110-111.
Crossref
Crossref
Andy Bush, Anne M. Fitzpatrick, Sejal Saglani, William C. AndersonIIIIII & Stanley J. Szefler. (2022) Difficult-to-Treat Asthma Management in School-Age Children. The Journal of Allergy and Clinical Immunology: In Practice 10:2, pages 359-375.
Crossref
Crossref
Chin Kook Rhee, Jung-Won Park, Heung-Woo Park & You Sook Cho. (2022) Effect of Dupilumab in Korean Patients With Uncontrolled Moderate-to-Severe Asthma: A LIBERTY ASTHMA QUEST Sub-analysis. Allergy, Asthma & Immunology Research 14:2, pages 182.
Crossref
Crossref
Alistair Cook, Peter A.B. Wark, Jasmine Wark & Jodie Simpson. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
278
295
.
Ramón Moreno-Luna, Ainhoa García-Lliberós de Miguel, Serafín Sánchez-Gómez & Alfonso del Cuvillo Bernal. 2022. Atlas of Frontal Sinus Surgery. Atlas of Frontal Sinus Surgery
317
327
.
Aleksandr G. Chuchalin, Sergey N. Avdeev, Zaurbek R. Aisanov, Andrey S. Belevskiy, Olga S. Vasilyeva, Natalya A. Geppe, Galina L. Ignatova, Nadezhda P. Kniajeskaia, Aleksandr B. Malakhov, Natalya N. Meshcheryakova, Natalia M. Nenasheva, Rustem S. Fassakhov, Rakhim M. Khaitov, Natalya I. Ilina, Oksana M. Kurbacheva, Natalia G. Astafyeva, Irina V. Demko, Daria S. Fomina, Leyla S. Namazova-Baranova, Alexander A. Baranov, Elena A. Vishneva, Gennadiy A. Novik, Alexander P. Bobkov & Laine Ya. Francuzevica. (2021) Asthma. Russian Journal of Allergy 18:4, pages 40-106.
Crossref
Crossref
Irina V Demko, Elena A. Sobko, Angelina Yu. Kraposhina, Natalia A. Shestakova, Natalia V. Gordeeva & Karina F. Kasymova. (2021) New opportunities of therapy of severe atopic dermatitis. Russian Journal of Allergy 18:3, pages 113-119.
Crossref
Crossref
Norihiro Harada, Jun Ito & Kazuhisa Takahashi. (2021) Clinical effects and immune modulation of biologics in asthma. Respiratory Investigation 59:4, pages 389-396.
Crossref
Crossref
Chiao-Juno Chiu & Miao-Tzu Huang. (2021) Asthma in the Precision Medicine Era: Biologics and Probiotics. International Journal of Molecular Sciences 22:9, pages 4528.
Crossref
Crossref
Jonathan Corren, Esther Garcia Gil, Janet M. Griffiths, Jane R. Parnes, Rene van der Merwe, Kinga Sałapa & Sean O'Quinn. (2021) Tezepelumab improves patient-reported outcomes in patients with severe, uncontrolled asthma in PATHWAY. Annals of Allergy, Asthma & Immunology 126:2, pages 187-193.
Crossref
Crossref
Gabriel García, Miguel Bergna, Juan C. Vásquez, Maria C. Cano Salas, José L. Miguel, Carlos Celis Preciado, Agustin Acuña Izcaray, Manuel Barros Monge, Natalia García Batista, Ignacio Zabert, José L. Mayorga, Renato Casanova Mendoza, Martha Gutierrez, Maria F. Montero Arias, Luzcenelia Urtecho Perez, Miguel Antúnez, Victoria Williams Derby, Alejandra Villatoro Azméquita, Luis Motiño, M. Alenita De Oliveira, Diana Rey Sanchez, Marisol Arroyo & Mario Rodriguez. (2021) Severe asthma: adding new evidence – Latin American Thoracic Society. ERJ Open Research 7:1, pages 00318-2020.
Crossref
Crossref
Ersilia Tolino, Ilaria Proietti, Antonella Sarni, Nicoletta Bernardini, Alessandra Mambrin, Veronica Balduzzi, Patrizia Maddalena, Anna Marchesiello, Simone Michelini, Salvatore Volpe, Nevena Skroza & Concetta Potenza. (2020) Success of dupilumab as a monotherapy in an adult patient affected by severe uncontrolled asthma and atopic dermatitis. Dermatologic Therapy 34:1.
Crossref
Crossref
Andrew Menzies-Gow, Gene Colice, Janet M. Griffiths, Gun Almqvist, Sandhia Ponnarambil, Primal Kaur, Gennaro Ruberto, Karin Bowen, Åsa Hellqvist, May Mo & Esther Garcia Gil. (2020) NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma. Respiratory Research 21:1.
Crossref
Crossref
Claire Emson, Sarah Diver, Latifa Chachi, Ayman Megally, Cherrie Small, John Downie, Jane R. Parnes, Karin Bowen, Gene Colice & Chris E. Brightling. (2020) CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma. Respiratory Research 21:1.
Crossref
Crossref
Andrew Menzies-Gow, Michael E. Wechsler & Chris E. Brightling. (2020) Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?. Respiratory Research 21:1.
Crossref
Crossref
Celeste M. Porsbjerg, Asger Sverrild, Clare M. Lloyd, Andrew N. Menzies-Gow & Elisabeth H. Bel. (2020) Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics. European Respiratory Journal 56:5, pages 2000260.
Crossref
Crossref
Ioana Agache, Yang Song, Claudio Rocha, Jessica Beltran, Margarita Posso, Corinna Steiner, Pablo Alonso‐Coello, Cezmi Akdis, Mubeccel Akdis, Giorgio Walter Canonica, Thomas Casale, Tomas Chivato, Jonathan Corren, Stefano del Giacco, Thomas Eiwegger, Davide Firinu, James E. Gern, Eckard Hamelmann, Nicola Hanania, Mika Mäkelä, Irene Hernández Martín, Parameswaran Nair, Liam O'Mahony, Nikolaos G. Papadopoulos, Alberto Papi, Hae‐Sim Park, Luis Pérez de Llano, Santiago Quirce, Joaquin Sastre, Mohamed Shamji, Jurgen Schwarze, Carlos Canelo‐Aybar, Oscar Palomares & Marek Jutel. (2020) Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma. Allergy 75:5, pages 1058-1068.
Crossref
Crossref
Ioana Agache, Claudio Rocha, Jessica Beltran, Yang Song, Margarita Posso, Ivan Solà, Pablo Alonso‐Coello, Cezmi Akdis, Mubeccel Akdis, Giorgio W. Canonica, Thomas Casale, Tomas Chivato, Jonathan Corren, Stefano Del Giacco, Thomas Eiwegger, Davide Firinu, James E. Gern, Eckard Hamelmann, Nicola Hanania, Mika Mäkelä, Irene Hernández Martín, Parameswaran Nair, Liam O'Mahony, Nikolaos G. Papadopoulos, Alberto Papi, Hae‐Sim Park, Luis Pérez de Llano, Santiago Quirce, Joaquin Sastre, Mohamed Shamji, Jurgen Schwarze, Carlos Canelo‐Aybar, Oscar Palomares & Marek Jutel. (2020) Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma. Allergy 75:5, pages 1043-1057.
Crossref
Crossref
Louise Selby & Louise J. Fleming. 2020. Severe Asthma in Children and Adolescents. Severe Asthma in Children and Adolescents
183
211
.
Deepa Rastogi & Andrew H. Liu. 2020. Difficult To Treat Asthma. Difficult To Treat Asthma
265
295
.
Magnus Ekström, Bright I. Nwaru, Pål Hasvold, Fredrik Wiklund, Gunilla Telg & Christer Janson. (2019) Oral corticosteroid use, morbidity and mortality in asthma: A nationwide prospective cohort study in Sweden. Allergy 74:11, pages 2181-2190.
Crossref
Crossref
Amelia Licari, Sara Manti, Riccardo Castagnoli, Alessia Marseglia, Thomas Foiadelli, Ilaria Brambilla & Gian Luigi Marseglia. (2019) Immunomodulation in Pediatric Asthma. Frontiers in Pediatrics 7.
Crossref
Crossref
Ekaterina O. Gubernatorova, Olga A. Namakanova, Alexei V. Tumanov, Marina S. Drutskaya & Sergei A. Nedospasov. (2019) Mouse models of severe asthma for evaluation of therapeutic cytokine targeting. Immunology Letters 207, pages 73-83.
Crossref
Crossref